• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞线粒体 DNA 诱导非酒精性脂肪性肝炎中巨噬细胞白细胞介素 33 的表达上调。

Mitochondrial DNA from hepatocytes induces upregulation of interleukin-33 expression of macrophages in nonalcoholic steatohepatitis.

机构信息

Department of Pathology and Hepatology, the 5th Medical Centre, Chinese PLA General Hospital, No. 100, Xisi Ring Middle Road, Beijing, 100039, China; Liver Transplantation and Research Center, the 5th Medical Centre, Chinese PLA General Hospital, No. 100, Xisi Ring Middle Road, Beijing, 100039, China.

Department of Pathology and Hepatology, the 5th Medical Centre, Chinese PLA General Hospital, No. 100, Xisi Ring Middle Road, Beijing, 100039, China.

出版信息

Dig Liver Dis. 2020 Jun;52(6):637-643. doi: 10.1016/j.dld.2020.03.021. Epub 2020 Apr 29.

DOI:10.1016/j.dld.2020.03.021
PMID:32360132
Abstract

OBJECTIVE

In the present study, we propose that lipotoxicity induces the release of mitochondrial DNA (mtDNA) from hepatocytes, which in turn upregulates IL-33 expression in macrophages.

METHODS

The mtDNA levels of plasma were determined in methionine- and mholine-deficient diet (MCD)-fed mice and NASH patients. Cultured hepatocytes were pre-incubated with Mito-TEMPO or rapamycin and were then stimulated with palmitic acid. The mtDNA levels in the cytosol were measured. The mtDNA from hepatocytes of mice was added to bone marrow-derived macrophages (BMDMs) in the presence of IRS (TLR9 antagonist). The expression of IL-33 in BMDMs was measured.

RESULTS

Levels of mtDNA were higher in NASH patients and MCD-fed mice. Treatment of hepatocytes with palmitic acid in vitro induced mtDNA release into cytosol, which was attenuated by mito-TEMPO or rapamycin, and aggravated by inhibition of autophagy. Treatment of BMDMs with mtDNA enhanced IL-33 expression, which was attenuated by knockdown of TLR9. Treatment of BMDMs with mtDNA enhanced lipopolysaccharide (LPS)-induced production of IL-1β and TNF-α, which was attenuated by pretreatment with soluble ST2.

CONCLUSION

mtDNA released from injured hepatocytes under lipid overload induced the upregulation of IL-33 expression in macrophages via TLR9, and enhanced LPS-induced inflammatory cytokine production.

摘要

目的

在本研究中,我们提出脂毒性诱导肝细胞释放线粒体 DNA(mtDNA),进而上调巨噬细胞中 IL-33 的表达。

方法

检测蛋氨酸和胆碱缺乏饮食(MCD)喂养的小鼠和 NASH 患者血浆中的 mtDNA 水平。培养的肝细胞先用 Mito-TEMPO 或雷帕霉素预处理,然后用棕榈酸刺激。测量细胞质中的 mtDNA 水平。在 IRS(TLR9 拮抗剂)存在的情况下,将来自小鼠肝细胞的 mtDNA 添加到骨髓来源的巨噬细胞(BMDM)中。测量 BMDM 中 IL-33 的表达。

结果

NASH 患者和 MCD 喂养的小鼠 mtDNA 水平更高。体外用棕榈酸处理肝细胞诱导 mtDNA 释放到细胞质中,该过程被 mito-TEMPO 或雷帕霉素减弱,被自噬抑制加重。用 mtDNA 处理 BMDM 增强了 IL-33 的表达,该过程被 TLR9 的敲低减弱。用 mtDNA 处理 BMDM 增强了脂多糖(LPS)诱导的 IL-1β 和 TNF-α 的产生,该过程被可溶性 ST2 的预处理减弱。

结论

脂质过载下受损肝细胞释放的 mtDNA 通过 TLR9 诱导巨噬细胞中 IL-33 的表达上调,并增强 LPS 诱导的炎症细胞因子产生。

相似文献

1
Mitochondrial DNA from hepatocytes induces upregulation of interleukin-33 expression of macrophages in nonalcoholic steatohepatitis.肝细胞线粒体 DNA 诱导非酒精性脂肪性肝炎中巨噬细胞白细胞介素 33 的表达上调。
Dig Liver Dis. 2020 Jun;52(6):637-643. doi: 10.1016/j.dld.2020.03.021. Epub 2020 Apr 29.
2
Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9.肝细胞线粒体DNA通过激活TLR9驱动非酒精性脂肪性肝炎。
J Clin Invest. 2016 Mar 1;126(3):859-64. doi: 10.1172/JCI83885. Epub 2016 Jan 25.
3
Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder.纤维蛋白原样蛋白 2 通过与 TLR4 相互作用加剧非酒精性脂肪性肝炎,在巨噬细胞中引发炎症,并诱导肝脂质代谢紊乱。
Theranostics. 2020 Aug 1;10(21):9702-9720. doi: 10.7150/thno.44297. eCollection 2020.
4
Macrophage p38α promotes nutritional steatohepatitis through M1 polarization.巨噬细胞 p38α 通过 M1 极化促进营养性脂肪性肝炎。
J Hepatol. 2019 Jul;71(1):163-174. doi: 10.1016/j.jhep.2019.03.014. Epub 2019 Mar 23.
5
TLR9 is up-regulated in human and murine NASH: pivotal role in inflammatory recruitment and cell survival.Toll样受体9(TLR9)在人类和小鼠非酒精性脂肪性肝炎(NASH)中表达上调:在炎症细胞募集和细胞存活中起关键作用。
Clin Sci (Lond). 2017 Jul 24;131(16):2145-2159. doi: 10.1042/CS20160838. Print 2017 Aug 15.
6
STING-mediated inflammation in Kupffer cells contributes to progression of nonalcoholic steatohepatitis.STING 介导的库普弗细胞炎症促进非酒精性脂肪性肝炎的进展。
J Clin Invest. 2019 Feb 1;129(2):546-555. doi: 10.1172/JCI121842. Epub 2018 Dec 18.
7
Galectin-3 Ablation Enhances Liver Steatosis, but Attenuates Inflammation and IL-33-Dependent Fibrosis in Obesogenic Mouse Model of Nonalcoholic Steatohepatitis.半乳糖凝集素-3缺失增强肝脏脂肪变性,但减轻非酒精性脂肪性肝炎致肥胖小鼠模型中的炎症和白细胞介素-33依赖性纤维化。
Mol Med. 2015 May 22;21(1):453-65. doi: 10.2119/molmed.2014.00178.
8
Scoparone improves hepatic inflammation and autophagy in mice with nonalcoholic steatohepatitis by regulating the ROS/P38/Nrf2 axis and PI3K/AKT/mTOR pathway in macrophages.山苍子素通过调节巨噬细胞中的 ROS/P38/Nrf2 轴和 PI3K/AKT/mTOR 通路改善非酒精性脂肪性肝炎小鼠的肝炎症和自噬。
Biomed Pharmacother. 2020 May;125:109895. doi: 10.1016/j.biopha.2020.109895. Epub 2020 Jan 28.
9
Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes.脂质诱导的信号传导导致肝细胞释放炎性细胞外囊泡。
Gastroenterology. 2016 Apr;150(4):956-67. doi: 10.1053/j.gastro.2015.12.037. Epub 2016 Jan 5.
10
Lipid-injured hepatocytes release sOPN to improve macrophage migration via CD44 engagement and pFak-NFκB signaling.脂滴损伤的肝细胞通过 CD44 结合和 pFak-NFκB 信号通路释放 sOPN 以促进巨噬细胞迁移。
Cytokine. 2021 Jun;142:155474. doi: 10.1016/j.cyto.2021.155474. Epub 2021 Feb 27.

引用本文的文献

1
Innate Immunity Receptor TLR9 Drives Erythrocyte Cholesterol and Ferroprotin Accumulation in a Glutaminase-Independent Manner. Implications for Metabolic Associated Fatty Liver Disease.固有免疫受体TLR9以不依赖谷氨酰胺酶的方式驱动红细胞胆固醇和铁转运蛋白积累。对代谢相关脂肪性肝病的意义。
Maedica (Bucur). 2025 Jun;20(2):220-227. doi: 10.26574/maedica.2025.20.2.220.
2
Advances in the acting mechanism and treatment of gut microbiota in metabolic dysfunction-associated steatotic liver disease.代谢功能障碍相关脂肪性肝病中肠道微生物群的作用机制及治疗进展
Gut Microbes. 2025 Dec;17(1):2500099. doi: 10.1080/19490976.2025.2500099. Epub 2025 May 20.
3
Mitochondrial DNA leakage: underlying mechanisms and therapeutic implications in neurological disorders.
线粒体DNA泄漏:神经疾病的潜在机制及治疗意义
J Neuroinflammation. 2025 Feb 7;22(1):34. doi: 10.1186/s12974-025-03363-0.
4
MiR-146a-5p-enriched exosomes inhibit M1 macrophage activation and inflammatory response by targeting CD80.富含 miR-146a-5p 的外泌体通过靶向 CD80 抑制 M1 巨噬细胞的激活和炎症反应。
Mol Biol Rep. 2024 Nov 8;51(1):1133. doi: 10.1007/s11033-024-10088-5.
5
Esrra regulates Rplp1-mediated translation of lysosome proteins suppressed in metabolic dysfunction-associated steatohepatitis and reversed by alternate day fasting.Esrra 调节 Rplp1 介导的代谢功能障碍相关脂肪性肝炎中受抑制的溶酶体蛋白的翻译,隔日禁食可逆转这种抑制。
Mol Metab. 2024 Sep;87:101997. doi: 10.1016/j.molmet.2024.101997. Epub 2024 Jul 19.
6
Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH).非酒精性脂肪性肝病/脂肪性肝炎(NAFL/NASH)中的靶向治疗和新型信号通路。
Signal Transduct Target Ther. 2022 Aug 13;7(1):287. doi: 10.1038/s41392-022-01119-3.
7
ROS-Induced mtDNA Release: The Emerging Messenger for Communication between Neurons and Innate Immune Cells during Neurodegenerative Disorder Progression.活性氧诱导的线粒体DNA释放:神经退行性疾病进展过程中神经元与固有免疫细胞间通信的新兴信使
Antioxidants (Basel). 2021 Nov 29;10(12):1917. doi: 10.3390/antiox10121917.
8
Endogenous Interleukin-33 Acts as an Alarmin in Liver Ischemia-Reperfusion and Is Associated With Injury After Human Liver Transplantation.内源性白细胞介素-33 在肝缺血再灌注中作为警报素起作用,并与肝移植后损伤相关。
Front Immunol. 2021 Sep 21;12:744927. doi: 10.3389/fimmu.2021.744927. eCollection 2021.
9
Mitochondrial DNA-Mediated Inflammation in Acute Kidney Injury and Chronic Kidney Disease.线粒体 DNA 介导的急性肾损伤和慢性肾脏病中的炎症反应
Oxid Med Cell Longev. 2021 Jun 29;2021:9985603. doi: 10.1155/2021/9985603. eCollection 2021.
10
TLR9 in MAFLD and NASH: At the Intersection of Inflammation and Metabolism.TLR9 在 MAFLD 和 NASH 中的作用:炎症与代谢的交汇点。
Front Endocrinol (Lausanne). 2021 Jan 29;11:613639. doi: 10.3389/fendo.2020.613639. eCollection 2020.